vimseltinib 30 MG Oral Capsule

RxCUI: 2705418
RxNorm name: vimseltinib 30 MG Oral Capsule
Display name: vimseltinib 30 MG Oral Capsule
Full name: vimseltinib 30 MG Oral Capsule
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ROMVIMZA	VIMSELTINIB	Deciphera Pharmaceuticals, LLC	f73c7a62-9601-4df0-810f-100f515d79ea	2026-06-26	Warnings, Adverse reactions	Exact identifier rxcui: 2705418

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
f73c7a62-9601-4df0-810f-100f515d79ea	vimseltinib 30 MG Oral Capsule [PSN] · vimseltinib 30 MG Oral Capsule [SCD]	2	2	These highlights do not include all the information needed to use ROMVIMZA TM safely and effectively. See full prescribing information for ROMVIMZA TM . ROMVIMZA TM (vimseltinib) capsules, for oral use Initial U.S. Approval: 2025	20251222